Does Fridays Use a 503A Pharmacy? Yes — and Here's Every Pharmacy It Names

Disclosure: Some links on this page are affiliate links, including links to Fridays and Ro. If you start a program through one, The RX Index may be paid a commission — at no extra cost to you. That does not change which records we checked, what we found, or what we tell you we couldn't confirm. Every claim below is tied to a document you can open yourself.

This page explains public records. It does not replace advice from your prescriber or pharmacist.

Does Fridays use a 503A pharmacy? Yes, according to Fridays. Its help center says all partner pharmacies use the 503A path. Its Terms & Conditions name four: RedRock Pharmacy, Health Warehouse, Precision Medicine, and Triad Rx. A separate help article names a fifth, SSP Pharmacy.

The evidence is not equally strong for all five. Red Rock and Precision identify themselves as 503A pharmacies. FDA lists Triad Rx as a 503A facility. HealthWarehouse's public site does not explain a compounding role. We could not confidently match SSP Pharmacy to a legal name, address, or state license from the name Fridays publishes.

That's the short answer. But there's a wrinkle almost nobody tells you about, and it's the opposite of what you've probably read.

Most articles imply 503A is the lesser category — the loose one, the one to worry about. That is too simple. A 503B outsourcing facility has stricter federal manufacturing and reporting rules. But semaglutide and tirzepatide are not now on FDA's 503B Bulks List, drug shortage list, or current Category 1 interim-policy list, so 503B facilities do not have a current bulk-ingredient path for making them. Fridays says it is using the patient-specific 503A path instead.

We'll show you exactly why, straight from the FDA's own pages. And we'll show you the one question that decides whether your prescription fits the path Fridays says it uses — because the pharmacy's name alone does not settle that.

Does Fridays use a 503A pharmacy? The quick verdict

This page is for you if: you're at checkout doing one last trust check, or a vial already showed up with a pharmacy name you've never heard of.

This page is not for you if: you only want an FDA-approved medication, or you need to choose your own pharmacy. Both are completely reasonable. Skip to that section — we'll point you somewhere better.

What Fridays says vs. what we could verify

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.

Which pharmacies does Fridays actually name?

Fridays names four partner pharmacies in its Terms & Conditions, last updated March 23, 2026: RedRock Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama. A separate help center article names a fifth, SSP Pharmacy. Fridays states it does not manufacture compounded medications itself.

Here's the part that takes work. Fridays makes a blanket statement — “all partner pharmacies are 503A-accredited” — but it doesn't tell you what each pharmacy actually does, or which one gets your order.

So we went pharmacy by pharmacy. We pulled what Fridays says, what each pharmacy says about itself, and what government records show. Then we labeled each finding by how strong the evidence is — because “the company told us” and “we found it in a federal record” are not the same thing, and no one should pretend otherwise.

The Fridays Pharmacy Evidence Matrix

Read the evidence column carefully. We did not collapse five different situations into one checkmark, because they aren't the same. Two pharmacies say plainly what they are. One has a federal record. One is named but its compounding role is never explained. One we simply couldn't pin down.

That last row is not us being lazy. We looked, and we came up empty. Saying so is more useful to you than guessing.

How can you verify Fridays' 503A claim yourself?

FDA's 503B registry is a useful one-way check, not a 503A certificate. We searched the registry for every pharmacy name Fridays publishes. None produced an exact-name match on the list updated August 28, 2026. That means none is listed under that exact name as a 503B outsourcing facility. It does not, by itself, prove 503A status.

Here's why that distinction matters.

Two federal compounding paths matter here. 503A covers patient-specific compounding by a state-licensed pharmacy, a federal facility, or a licensed physician that is not registered as a 503B outsourcing facility. 503B covers outsourcing facilities that register with FDA, follow current good manufacturing practice rules, and can make batches without first receiving a prescription for a named patient.

FDA publishes a list of registered 503B outsourcing facilities. There is no matching federal master list of every 503A pharmacy because state boards are the main day-to-day licensing authorities for those pharmacies.

A no-match result has limits. A pharmacy may use a legal entity name that differs from its brand. An affiliate may be registered under another name. The pharmacy on a telehealth site's list may also play a role that has nothing to do with compounding.

Run the check yourself

We'd rather you check than take our word for it.

1. Read the legal pharmacy name, address, and phone number on your vial or prescription paperwork.
2. Search that legal name on FDA's Registered Outsourcing Facilities page.
3. If there is no exact match, use FDA's state pharmacy-license lookup page to open the board database for your state.
4. Match the legal name, address, license status, and phone number — not just the logo or marketing name.

A 503B match means the listed legal entity is registered as an outsourcing facility. No exact match only means you did not find that exact legal name on the 503B list. It is not a federal stamp saying “503A.”

The records look solid enough for your next step? A licensed provider still has to review your health history and decide whether a prescription is appropriate. → See Fridays' current program and pricing (affiliate link)

What is a 503A pharmacy, in plain English?

A 503A pharmacy is a state-licensed pharmacy that compounds medication for an identified patient from a valid prescription, with limited room for advance preparation based on past prescribing patterns. It is the traditional patient-specific compounding path. State boards provide the main day-to-day oversight, while FDA can still inspect, investigate, and enforce federal law.

The other category, 503B, came out of the 2012 fungal meningitis outbreak traced to contaminated compounded drugs. Congress created a new outsourcing-facility path in 2013: register with FDA, follow federal drug-manufacturing rules, undergo FDA oversight, and meet added labeling and reporting duties. These facilities often supply hospitals and clinics.

Now here's what each path actually buys you. We built this from FDA's own side-by-side chart of the two sections — not from another blog's summary.

Two things to sit with.

First, the honest downside. A 503A pharmacy that meets the section's conditions is exempt from federal current good manufacturing practice requirements. It does not have the same mandatory federal adverse-event reporting duty as a 503B facility. Those are real gaps, and anyone telling you 503A is identical to a factory-made FDA-approved drug is selling you something.

Useful checks include the exact legal pharmacy name, an active state license, inspection and enforcement history, the formulation on your label, access to a pharmacist, and any current voluntary accreditation. PCAB accreditation through ACHC is one extra signal. It is not a guarantee, and it is not the same thing as 503A status.

Second, one correction that matters. Fridays' help pages use the phrase “503A-accredited.” 503A is a section of federal law, not an accreditation program. Pharmacies are licensed by state boards. Some separately earn voluntary accreditation such as PCAB. Fridays' wording sounds stronger than it is.

And the compliance line we won't blur: compounded medications are not FDA-approved. FDA does not review them before marketing for safety, effectiveness, or quality. Fridays says this in its own footer. That's true no matter which pharmacy fills the order.

Does “FDA-registered facility” mean FDA-approved?

No. “FDA-registered” does not mean FDA-approved, FDA-licensed, or proven safe. Fridays says its compounded medications are produced in “FDA-registered facilities,” but that phrase does not tell you which entity is registered or what role it plays.

For example, bulk ingredients used in 503A compounding must come from an establishment registered with FDA under Section 510. That can make the ingredient maker an FDA-registered establishment. It does not turn the dispensing pharmacy into a 503B outsourcing facility, and it does not turn the final compounded drug into an FDA-approved product.

FDA says establishment registration and drug listing do not show that a product is approved or that FDA has verified the submitted information. FDA also says it does not approve or license compounding facilities.

The clean question is:

“Which legal entity is FDA-registered, and what is it registered to do?”

A real answer should name the entity and its role. “Made in an FDA-registered facility” by itself is not enough to answer either question.

Is 503A worse than 503B?

Neither number is a quality grade. They're two different legal models built for two different jobs — one named patient at a time versus registered batch production. A 503B facility has stricter federal manufacturing, inspection, labeling, and reporting duties. A 503A pharmacy has the patient-specific path Fridays says it uses.

This is where most articles on this topic go badly wrong, and it's worth being blunt about.

A 503B facility can compound from bulk ingredients only if the substance is on FDA's 503B Bulks List, or if the drug made from it is on FDA's drug shortage list at the time of compounding, distribution, and dispensing. FDA also has an interim enforcement policy for substances on its Category 1 list while nominations are evaluated. As of August 28, 2026, semaglutide and tirzepatide are on none of those three lists.

That does not support the sweeping claim that a 503B facility can never compound any altered semaglutide or tirzepatide product under any circumstance. It does mean there is no current 503B path for making these drugs from bulk semaglutide or tirzepatide API. A page that tells you to demand a “503B semaglutide pharmacy” without explaining that limit is leaving out the central rule.

FDA proposed on April 30, 2026, to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List. The public comment period closed July 30, 2026. FDA had not issued a final decision when we checked on August 28, 2026.

Which reframes the whole question you came here with. Fridays using a 503A network is not, by itself, the shaky part. The real questions are whether the exact pharmacy is licensed, what it made for you, and whether your prescriber documented the patient-specific difference required for routine copy compounding.

Is compounded semaglutide still legal in 2026?

Yes, but the broad shortage-based copy window is over. FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025. The later enforcement periods also ended. For a 503A product that would otherwise be essentially a copy, the main routine path above FDA's narrow four-prescription enforcement threshold is patient-specific: the prescriber must determine that a change produces a significant difference for that patient. That finding should be on the prescription, or the compounder must confirm it with the prescriber and add a specific notation. Other federal and state rules still apply.

Here's the timeline, dated, so you can see how we got here:

That last row is why the “last verified” date at the top of this page matters. This is live, and an undated answer can age into a wrong one.

What makes a Fridays prescription fit the 503A rules?

Federal law restricts a 503A compounder from making drugs that are essentially copies of commercially available products “regularly or in inordinate amounts.” FDA says the key exception is a change that the prescriber determines will produce a significant difference for an identified patient. That finding should be on the prescription. If it is not, the compounder can confirm it with the prescriber and add a specific notation.

Read that again, because it's the whole ballgame.

The pharmacy's number does not make your prescription fit the rule. The patient-specific prescription and the documented significant-difference decision are the key federal pieces for the routine path Fridays describes.

FDA says the prescription should identify the relevant change and the significant difference it produces for that patient. A patient name and formulation alone are not enough. If the prescription does not make the determination clear, the compounder can confirm it with the prescriber and make a specific, dated notation on the prescription.

Three things that do not settle the question

• A lower price does not identify a change in the drug. Cost may decide what you can afford, but the significant-difference rule asks what is different about the compounded product for you.
• A prescription with your name is required, but it does not answer every copy question by itself. For regular compounding above FDA's narrow enforcement threshold, the prescriber determination is the missing piece.
• Adding B12 does not automatically solve it. FDA used this exact example on April 1, 2026: semaglutide combined with vitamin B12 may still be treated as essentially a copy when it uses the same route and both ingredients are within 10% of the strengths in commercially available products.

That last one is not hypothetical here. Red Rock Pharmacy publicly links materials for semaglutide with vitamin B12, semaglutide with glycine, tirzepatide with vitamin B12, and tirzepatide with glycine. So what's printed on your vial isn't trivia. It's the thing the whole question turns on.

The “four prescriptions” rule everyone gets backwards

You may run into a claim that FDA allows four compounded prescriptions per patient, per month. That is wrong.

FDA's April 1, 2026 statement says the agency does not intend to take action under this part of the copy policy if the compounder fills four or fewer prescriptions of that compounded drug product during a calendar month.

Four prescriptions for the compounder. For that compounded product. During the whole month.

It is not a four-prescriptions-per-patient allowance. It is a narrow enforcement threshold, not a permission slip for a national program to make routine copies.

So how does Fridays still offer this?

Fridays answers that itself in a help article dated April 30, 2026. It says compounding remains an option for personalized care and lists custom dosing, alternative ingredients or forms, and personalized formulations. It also says its microdosing program uses compounded formulations because brand-name products come in fixed doses.

That's Fridays describing the documented-difference path in marketing language. The missing piece is still individual: did your prescriber make and document that determination for you?

The one question to ask — copy this

Send it through your Fridays portal message thread, so you have the answer in writing:

“What specific change in my compounded prescription produces a significant difference for me compared with an FDA-approved product, and is that determination written on the prescription sent to the compounder?”

A clear answer is a good sign. A reply that only says “it's the same medicine for less money” does not identify a patient-specific change. That's your cue to slow down and ask again.

We're handing you this for free because you should have it whether or not you ever click a link on this page. That's the point of the page.

Know what to ask now? Review Fridays' current program, then send your provider that exact question before your first vial ships. Get the answer in writing before you decide whether to use it. → See Fridays' current program and pricing (affiliate link)

Can you choose which pharmacy fills your Fridays order?

No. Fridays states in its own help center that the pharmacy is predetermined by your dose and location, and that it “cannot control or change which pharmacy fulfills your order.” You can raise a preference with your provider, but the final assignment depends on location, dose, and state rules.

This is the real limitation on this page, and we're not going to dress it up.

Fridays does not let you pick your pharmacy — and it doesn't publish a state-by-state or product-by-product map of which pharmacy goes where. If choosing the specific pharmacy that makes your medication is a priority for you, a local compounding pharmacy working with a local prescriber is a better fit, and you should take that path instead. Our Find My GLP-1 Path tool can point you toward providers with different fulfillment models.

That matters more than usual if you've reacted to an added ingredient before, need a specific concentration, or want the same pharmacy on every refill.

Fridays gives a reason for the routing: dose, geography, and state rules. But it does not publish the routing map. That means you cannot confirm the dispensing pharmacy from the sales page before you enroll.

And you're not in the dark forever. You can find out which pharmacy made your vial from the prescription label. Here's how.

How do you check your own vial before the first dose?

The pharmacy that prepared your medication should be identified on the prescription label and paperwork in the box. Compare the legal name, address, and phone number with Fridays' four-name terms list and the SSP mention in its help center. If the name is not on either list, that is not automatic proof of a problem — but verify it in writing and through the state board before you use the product.

Do this before your first dose, and again any time a refill looks different.

Check the label for:

• Your name, spelled correctly
• The pharmacy's legal name, city, state, and phone number
• Your prescriber's name
• The medication and form
• The concentration — how much medication is in each milliliter
• Any added ingredients such as B12, glycine, or preservatives
• Your dose written in milligrams, plus syringe-unit directions if the pharmacy provided them
• The syringe size that came in the box
• Storage instructions
• The beyond-use date — the date after which the pharmacy says not to use it
• A lot number, if one is printed
• Whether the seal is intact and the liquid looks the way the pharmacy described
• Whether the pharmacy, concentration, or added ingredients changed from your last refill

That concentration line is not a formality. FDA has reported dosing errors with compounded injectable GLP-1s caused by confusion between milligrams, milliliters, and syringe units. Some people took several times the intended dose, and some reports involved hospital care. If your directions and syringe do not clearly match, stop and call the pharmacy on the label before you inject anything. Don't do the math from a forum post or video.

Same rule for storage. Fridays says most shipments include ice packs, but says SSP Pharmacy's product is shelf-stable and does not need them. Follow the storage instructions for the exact product in your hand. FDA says not to use an injectable GLP-1 that arrives warm or with too little refrigeration when its instructions require refrigeration. Call the pharmacy or your provider first.

One more thing worth knowing

FDA warned in June 2026 about fraudulent compounded semaglutide and tirzepatide labels. In some cases, the named pharmacy did not exist. In other cases, the label used the name of a real licensed pharmacy that FDA said did not make the product.

That is why a name on a label is the start of the check, not the end.

1. Look up the pharmacy through the state board database.
2. Match the legal name and address.
3. If anything conflicts, call a phone number from the board record or pharmacy's official site — not only the number printed on the vial.

The published list tells you the expected pool. The label and license record tell you who says they made yours.

What does the public record show on each pharmacy?

The record is uneven. Red Rock and Precision describe themselves as 503A pharmacies. HealthWarehouse does not publicly explain a compounding role. FDA lists Triad Rx as a 503A facility and closed its warning letter in 2023. SSP remains unresolved from the name Fridays publishes. Here's what we found, including what we couldn't settle.

RedRock Pharmacy — St. George, Utah

Red Rock describes itself as a 503A compounding pharmacy, says it serves patients and providers in 49 states, and says it performs sterile and non-sterile compounding under USP chapters 795, 797, and 800.

One original mismatch we found: Fridays' terms pair Red Rock's St. George address with 801-433-9500. Red Rock's own location page assigns that number to its Salt Lake City location and lists 435-703-2900 for St. George. That may be a central contact choice, but Fridays does not explain it. Use the legal name, address, and phone number on your actual label, then compare them with the state license record.

Health Warehouse — Florence, Kentucky

This is the interesting one. HealthWarehouse describes itself as a nationwide digital pharmacy that ships FDA-approved prescription drugs, over-the-counter products, and veterinary medication. It says it is licensed or accredited with all 50 state boards.

We are not going to guess what it does for Fridays. It is named as a partner. Its public description does not explain a compounding program. Fridays does not explain the gap. If that bothers you, it is a fair thing to ask support about — and a fair reason not to treat Fridays' blanket 503A statement as independent proof for this one pharmacy.

Precision Medicine — Bellmore, New York

Precision Medicine describes itself as a 503A compounding and fulfillment pharmacy built for telehealth brands. It says it maintains USP 795, 797, and 800 environments for sterile injectables, non-sterile products, and hazardous compounds.

That is direct evidence from the pharmacy, not an FDA certification of each finished product. Which Fridays products and states Precision handles remains unpublished.

Triad Rx — Daphne, Alabama

This one has a record, and you deserve the whole thing rather than a scary fragment or a whitewash.

• July 2017 — FDA inspected Triad Rx.
• February 5, 2019 — FDA issued a warning letter. FDA said some products failed to meet Section 503A conditions and cited serious deficiencies in sterile-drug production practices.
• December 2022 — FDA inspected the pharmacy again and later issued a state referral letter.
• May 3, 2023 — FDA closed out the 2019 warning letter. FDA said Triad had adequately addressed the cited violations and acknowledged that the firm no longer produced sterile drug products.

The honest read: this is a closed warning letter, not an open one. FDA said the cited violations were adequately addressed. FDA also said Triad no longer produced sterile drugs. Injectable GLP-1s are sterile products. So the public record does not show that Triad currently makes Fridays' injectables; it may handle oral or other non-sterile products instead. Fridays doesn't publish the division of labor, so neither can we.

SSP Pharmacy

Fridays names SSP Pharmacy in a shipping note and says its compounded medication is shelf-stable and does not require ice packs. The article does not give a legal name, location, address, or license number.

We could not confidently connect “SSP Pharmacy” to a public legal entity from that name alone. That's an unresolved fact, not an automatic red flag. But if SSP is the name on your box, asking Fridays for its legal name and address is a completely reasonable request — and you should get a straight answer.

Does Fridays share pharmacies with other GLP-1 brands?

Yes. The same four pharmacy entries — Red Rock, Health Warehouse, Precision Medicine, and Triad Rx — appear in the published partner lists of Embody and altRx with matching street addresses and phone numbers. All three brands also publish ties to OpenLoop for clinical services, although Fridays says it uses OpenLoop Healthcare Partners and other networks.

We compared each brand's own published disclosures side by side:

One naming difference: Embody uses Precision Compounding Pharmacy for the Bellmore entry. Precision Medicine says that was its former name; the address and phone number match.

Same addresses. Same phone numbers. Different logos.

Here's why we're telling you this, and it might save you money. A higher telehealth price does not prove you are buying access to a different pharmacy network. At least three brands publish the same four names.

That does not mean every prescription, formulation, testing process, support team, or care plan is identical. It does mean “premium pharmacy network” is not enough by itself to justify a higher price when the disclosed buildings are the same.

Compare the things you can actually verify: the real monthly price, what happens at renewal, how much notice you need to cancel, which formulation is on your prescription, how fast refills ship, and whether you can reach a human when something goes wrong.

That's a better use of your attention, and it's the comparison we'd rather you win.

What can Fridays member reviews tell you about its pharmacies?

Member feedback can tell you about delivery, packaging, and support. It cannot prove that a pharmacy met its standards on a given batch — no customer review can. Read experience reports as experience, not as proof of quality.

One thing you should know before you weigh any Fridays testimonial:

Fridays labels its own success-story members as paid for their testimonials. Paid testimonials are not automatically false or unlawful, but they are marketing evidence, not independent proof. We did not use them to establish pharmacy status, sterility, potency, or legal compliance anywhere on this page.

Who should skip the compounded path entirely?

If you want a medication that FDA has reviewed for safety, effectiveness, and quality, a compounded GLP-1 is not it — regardless of which pharmacy makes it. That's a legitimate reason to choose a different treatment path, and for some people it isn't a close call.

We'd rather lose you here than have you find out later.

Choose a different path if:

• You want an FDA-approved medication and nothing else
• You have insurance that might cover Wegovy or Zepbound and you haven't actually checked yet
• You want a drug made under federal current good manufacturing practice rules
• You need to choose your own pharmacy
• You've reacted to an added ingredient before and need to control the formulation
• You won't proceed without lot-specific testing documentation

If you're in that group, the FDA-approved lane is a real option and worth pricing out before you assume you can't afford it.

Ro is the provider we point readers toward when they want an FDA-approved medication. Its free coverage checker currently checks the Ozempic pen, Wegovy pen, and Zepbound pen. Ro also offers cash-pay access to the Wegovy pill, Foundayo pill, and Zepbound KwikPen, but its checker does not verify insurance for those three options.

As verified August 28, 2026, the Ro Body membership is $39 for the first month, then $149 per month on the monthly plan or as low as $74 per month with an annual plan paid upfront. Medication is separate. Medicare, Medicare supplement, and TRICARE members may still qualify for some cash-pay options. FEHB members can use Ro's insurance concierge. Medicaid and some other government-plan members are not eligible through Ro at this time.

Want an FDA-approved medication instead? Find out whether your plan may cover an eligible pen before you pay cash for anything. → See my FDA-approved GLP-1 options with Ro (affiliate link)

Still weighing compounded against FDA-approved? That's the most common fork on this whole topic, and the right answer depends on your state, your plan, and your budget. Get my personalized GLP-1 action plan →

What did we actually verify?

We think you should know exactly how much of this page is checked and how much isn't.

Verified from primary or official sources on August 28, 2026:

• Fridays' Terms & Conditions partner-pharmacy list: four names, addresses, and phone numbers; last updated March 23, 2026
• Fridays' help center statements: its blanket 503A claim, third-party-testing claim, base-form claim, routing policy, and SSP Pharmacy shipping note
• Fridays' April 30, 2026 help article explaining its stated reasons for continued compounded prescribing
• FDA's side-by-side 503A and 503B requirements
• FDA's Registered Outsourcing Facilities list, updated August 28, 2026 — searched under every name Fridays publishes
• FDA's April 1, 2026 GLP-1 compounding update, including the significant-difference rule, B12 example, four-prescription threshold, and 503B bulk-ingredient restriction
• FDA's current Category 1 interim-policy list, checked for semaglutide and tirzepatide
• FDA's shortage-resolution and enforcement timeline for semaglutide and tirzepatide
• FDA's April 30, 2026 proposal on the 503B Bulks List and the July 30 extended comment deadline
• FDA's June 2026 warning about fraudulent compounded GLP-1 labels, refrigeration problems, and dosing errors
• Triad Rx's 2019 FDA warning letter, FDA action listing, and 2023 closeout
• Red Rock's, HealthWarehouse's, and Precision Medicine's descriptions on their own sites
• The Red Rock phone-number mismatch between Fridays' terms and Red Rock's official location page
• Published pharmacy disclosures for Embody and altRx
• Ro's current checker scope, program pricing, and government-plan limits

Not verified — and we're not pretending otherwise:

• Which pharmacy will fill any specific person's prescription
• Every partner's complete state-license portfolio
• Every formulation, concentration, or added ingredient Fridays offers
• Any lot-specific potency, sterility, or stability report
• Whether Fridays' testing claim applies to every lot shipped to every patient
• SSP Pharmacy's legal identity, address, and licensure
• HealthWarehouse's actual role in Fridays' compounded fulfillment
• Which legal entity Fridays means when it says “FDA-registered facilities”
• Whether a specific prescriber made and documented the required significant-difference determination on any reader's prescription, or whether a compounder confirmed it and made a specific notation

How this page was made: We read Fridays' terms and help articles, searched FDA's federal databases, read FDA's guidance and Federal Register materials, checked the pharmacies' public pages, and compared the partner disclosures of three telehealth brands. We are not Fridays patients and we did not place a test order. Everything here comes from documents you can open yourself — which is exactly why every claim points at one.

This page doesn't carry an RX Index Score. Scoring a provider takes a full review across clinical legitimacy, care quality, transparency, access, and cost, and a sourcing question isn't that. Read our full Fridays GLP-1 review →

Frequently asked questions

Does Fridays use a 503A pharmacy?

Yes, according to Fridays. Its help center says all partner pharmacies use the 503A path. Red Rock and Precision identify themselves as 503A pharmacies, and FDA lists Triad Rx as a 503A facility. HealthWarehouse's compounding role and SSP Pharmacy's legal identity remain unclear from the public pages we found.

Which pharmacies does Fridays use?

Its Terms & Conditions name four: RedRock Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama. A help center article also names SSP Pharmacy.

Did Fridays' pharmacies appear on FDA's 503B list?

We found no exact-name match for RedRock Pharmacy, Red Rock Pharmacy, Health Warehouse, HealthWarehouse, Precision Medicine, Triad Rx, or SSP Pharmacy on FDA's Registered Outsourcing Facilities list updated August 28, 2026. A no-match result is not proof of 503A status because a legal entity or affiliate may use a different name.

Which pharmacy will fill my prescription in my state?

Fridays does not publish a state-by-state map. It says the assignment depends on your location, dose, and state rules. The legal pharmacy name and address on your prescription label or pharmacy paperwork are the reliable answer for your shipment.

Can I request a specific pharmacy, like Red Rock?

You can raise a preference or concern with your provider, but Fridays says it cannot control or change which pharmacy fulfills your order.

Is a 503A pharmacy FDA-approved?

No. A pharmacy may be state-licensed and operate under Section 503A, but that does not make the pharmacy or its compounded medications FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality.

Does “FDA-registered facility” mean the medication is FDA-approved?

No. Registration is not approval. A bulk-ingredient manufacturer or another drug establishment may be registered with FDA, but that does not make the final compounded product FDA-approved or prove that the dispensing pharmacy is a 503B outsourcing facility.

Is 503B safer than 503A?

503B is not a quality grade, but it does carry stricter federal manufacturing, inspection, labeling, and adverse-event reporting duties. 503A is the patient-specific path. For semaglutide and tirzepatide, 503B facilities currently have no bulk-ingredient path because neither drug is on FDA's 503B Bulks List, drug shortage list, or current Category 1 interim-policy list.

Is compounded semaglutide still legal in 2026?

Yes, but the broad shortage-based copy window is over. For a 503A product that would otherwise be essentially a copy, the main routine route above FDA's narrow four-prescription enforcement threshold is patient-specific: the prescriber must determine that a change produces a significant difference for that patient. That finding should be on the prescription, or the compounder must confirm it with the prescriber and add a specific notation. All other federal and state rules still apply.

Does adding B12 make a compounded GLP-1 fit the rule?

Not automatically. FDA specifically used semaglutide combined with vitamin B12 as an example of a product it may still treat as essentially a copy when it uses the same route and the ingredient strengths are within 10% of commercially available products.

How do I find out which pharmacy made my medication?

Read the legal pharmacy name, address, and phone number on the prescription label and paperwork. Then check the pharmacy through your state board's license database. If the label conflicts with the board record or official pharmacy site, do not use the medication until the pharmacy or provider resolves it.

What is SSP Pharmacy?

It is a name in a Fridays shipping article. Fridays says SSP's compounded product is shelf-stable and does not need ice packs. The article does not give a legal name, address, or license number, and we could not confidently match the name to a public legal entity.

Does Fridays make the medication itself?

No. Fridays states that it does not manufacture compounded medications. It connects users with outside clinical practices and pharmacies. Fridays says clinical services are provided by OpenLoop Healthcare Partners and other networks.

Are Fridays' pharmacies “503A-accredited”?

That phrase is not technically clean. Section 503A is a federal legal path, not an accreditation program. Pharmacies are licensed by state boards and may separately earn voluntary accreditation such as PCAB through ACHC.

The bottom line

Yes, Fridays says it uses 503A pharmacies. Its terms name four, and its help center mentions a fifth. Red Rock and Precision identify themselves as 503A pharmacies. FDA lists Triad Rx as a 503A facility. HealthWarehouse's compounding role and SSP Pharmacy's legal identity remain unresolved from the public record.

None of the published names produced an exact match on FDA's 503B registry when we checked August 28, 2026. But a no-match result is not a 503A certificate.

The number on the pharmacy is not what protects you. Verify the legal pharmacy on your label, check its state license, and ask what patient-specific change your prescriber documented on the prescription. Ask the question. Read the label. Then decide with your eyes open.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

Sources

• Fridays — Terms & Conditions, last updated March 23, 2026
• Fridays Help Center — Compounding Pharmacies
• Fridays Help Center — How Does Fridays Continue to Offer Compounded Medications?
• Fridays — Contact and compounded-medication disclosures
• Fridays — Weight Loss page and paid-testimonial disclosure
• FDA — FD&C Act Provisions That Apply to Human Drug Compounding
• FDA — Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A
• FDA — What to Know When Promoting Compounded Drugs
• FDA — Human Drug Compounding Laws
• FDA — Registered Outsourcing Facilities
• FDA — GLP-1 compounding policy updates
• FDA — Bulk drug substances used under Section 503B
• FDA — Current 503B Category 1 interim-policy list
• FDA — Electronic Drug Registration and Listing System
• FDA — Concerns With Unapproved GLP-1 Drugs Used for Weight Loss
• FDA — Proposal on semaglutide, tirzepatide, and liraglutide for the 503B Bulks List
• Federal Register — 503B Bulks List proposal, May 1, 2026
• Federal Register — Comment-period extension to July 30, 2026
• FDA — Locate a State-Licensed Online Pharmacy
• FDA — Triad Rx warning letter, February 5, 2019
• FDA — Triad Rx closeout letter, May 3, 2023
• FDA — Triad Rx state referral letter, May 3, 2023
• FDA — Compounding inspections, recalls, and other actions
• ACHC — PCAB Compounding Pharmacy Accreditation
• Red Rock Pharmacy — About, formulation links, and official location phone numbers
• HealthWarehouse — About HealthWarehouse
• Precision Medicine — 503A and telehealth fulfillment and company history/former name
• Embody — Published partner pharmacies and clinical network
• altRx — Published partner pharmacies and clinical network
• Ro — GLP-1 coverage checker, program pricing, and insurance details
• FDA — Wegovy tablets approval letter and Foundayo prescribing information

Last verified August 28, 2026. The date changes only after the FDA records and Fridays' published pharmacy disclosures are checked again.